资讯

The significance of the inter-relationship between tumour and host local/systemic inflammatory responses in primary operable invasive breast cancer is limited. The inter-relationship between the ...
Proliferative lesions of the mammary gland are risk markers and potential precursors for the development of breast cancer in postmenopausal women. In this study we evaluated mammary epithelial ...
About AXPAXLI AXPAXLI™ (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with ...
The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...
In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ischemia, vascular leakage, and microaneurysm count at 3 and 6 months in patients ...
In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical ...
Stephanie J. London, Evan A. Stein, I. Craig Henderson, Meir J. Stampfer, William C. Wood, Steven Remine, Jan R. Dmochowski, Nicholas J. Robert, Walter C. Willett, Carotenoids, Retinol, and Vitamin E ...
The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
MONDAY, July 7, 2025 (HealthDay News) -- Patients undergoing retinal detachment (RD) repair with concomitant cannabis use have a lower risk for subsequent proliferative vitreoretinopathy (PVR) and ...
FORT LAUDERDALE, Fla. — Early pars plana vitrectomy may be a low-cost, definitive treatment for patients with proliferative diabetic retinopathy, according to a speaker at the Retina World Congress.
We learn more about the CellCelector, its applications, how it overcomes the limitations of other instruments and top tips ...
A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following ...